News & Media

Discover our latest news, innovations and advances in alpha-immunotherapy.

A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211

Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna.

This work was performecd by N. Varmenot from Institut de Cancérologie de l’Ouest in collaboration with Atonco and University of Michigan Medical Center, Ann Arbor

Link to the document : https://atonco-pharma.com/wp-content/uploads/2026/11/EP-1239-2.pdf